
Cefser S 250mg/125mg Injection
Marketer
Serene Lifeworld Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefser S 250mg/125mg Injection
Cefser S 250mg/125mg Injection, a dual-action antibiotic, combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this medication requires adherence to the prescribed dosage schedule. Complete the full course of treatment, even with symptom improvement, as premature cessation can reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects warrant immediate medical attention. Seek immediate help for allergic reactions like rashes, itching, swelling, or breathing difficulties. Inform your physician about all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, a balanced diet, and hydration support recovery. Your doctor may order tests to monitor treatment response.
Primary Ingredients of Cefser S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefser S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefser S 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefser S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefser S 250mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; patient self-administration is strictly prohibited.
How Cefser S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefser S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Cefser S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefser S (250mg/125mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Cefser S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Cefser S 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefser S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Cefser S 250mg/125mg Injection to individuals with severe hepatic impairment requires careful consideration and potential dosage modification. Patients with mild to moderate liver dysfunction, however, do not typically necessitate dose adjustments for Cefser S 250mg/125mg Injection. Physician consultation is advised.
What if you forget to take Cefser S 250mg/125mg Injection :
Should you omit a scheduled dose of Cefser S 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Cefser S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
